Cognitive Ability, General Clinical Trial
Official title:
A Combined Exercise Program Plus Cognitive Training for Older Adults With Self-reported Cognitive Complaints: The Multi-modal, Mind-motor (M4) Study
Verified date | September 2016 |
Source | Lawson Health Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Institutional Review Board |
Study type | Interventional |
The purpose of this study is to investigate whether an exercise class with a cognitive (or brain) training component was more effective than a usual combined aerobic and resistance exercise class for older adults with cognitive complaints (such as concerns about changes in memory or thinking skills). It is hypothesized that the group randomized to the exercise class that includes additional brain training will have greater improvements in brain health.
Status | Completed |
Enrollment | 127 |
Est. completion date | March 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 55 Years and older |
Eligibility |
Inclusion Criteria: - aged 55 years or older - self-reported cognitive complaint (defined as answering yes to the question "Do you feel like your memory or thinking skills have gotten worse recently?). - independent on instrumental activities of daily living Exclusion Criteria: - Probable Dementia (i.e., diagnosis OR Mini-Mental State Examination score <24) - Other neurological conditions or major psychiatric disorders (i.e., Parkinson's disease; bipolar disorder) - Previous history of severe cardiovascular conditions (i.e., myocardial infarction or stroke <1-year ago; end stage congestive heart failure; end stage renal disease) - Severe sensory impairment (i.e., blind) - Significant orthopedic conditions (i.e., severe osteoarthritis) - Clinical depression (determined via >=16 on the Center for Epidemiologic Studies - Depression Scale AND review by primary study physician) - Have blood pressure >180/100 mmHg or <100/60 mmHg - Unable to comprehend questionnaire material - Any other factors that could potentially limit ability to fully participate in the intervention |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Canada | Gymnasium | Woodstock | Ontario |
Lead Sponsor | Collaborator |
---|---|
Lawson Health Research Institute | Canadian Institutes of Health Research (CIHR) |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Prosaccade reaction time in response to flash of light. | The reaction time of the eye when instructed to look toward a flash of light. | 6 months | No |
Other | Change in blood flow to the pre-frontal cortex in response to a randomly selected cognitive task. | Neuroimaging assessment with functional magnetic resonance imaging | 6 months | No |
Other | Antisaccade reaction time in response to flash of light. | The reaction time of the eye when instructed to look away from a flash of light. | 6 months | No |
Other | Change in blood flow to the parietal cortex in response to a randomly selected cognitive task. | Neuroimaging assessment with functional magnetic resonance imaging | 6 months | No |
Primary | Composite score from Cambridge Brain Sciences Cognitive Battery - 12 tasks | To assess global cognitive function | 6 months | No |
Secondary | Composite score from Cambridge Brain Sciences Cognitive Battery - 12 tasks | To assess global cognitive function | 12 months | No |
Secondary | Gait variability (stride time) under dual-task conditions | Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as the coefficient of variation of step length (SD/mean x100). Measured with GAITRite system. | 6 & 12 months | No |
Secondary | Gait variability (stride time) under single-task conditions | Gait variability is the stride-to-stride fluctuations of the way someone walks and will be calculated as the coefficient of variation of step length (SD/mean x100). Measured with GAITRite system. | 6 & 12 months | No |
Secondary | Gait velocity (speed) under dual-task conditions | Average walking speed (gait velocity) measured with the GAITRite system | 6 & 12 months | No |
Secondary | Gait velocity (speed) under single-task conditions | Average walking speed (gait velocity) measured with the GAITRite system | 6 & 12 months | No |
Secondary | Step length (average) under dual-task conditions | Mean step length calculated from GAITRite system | 6 & 12 months | No |
Secondary | Step length (average) under single-task conditions | Mean step length calculated from GAITRite system | 6 & 12 months | No |
Secondary | Carotid Artery Compliance | Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck). | 6 & 12 months | No |
Secondary | Carotid Artery Intima-media thickness | Measured from non-invasive vascular assessment with B-mode Ultrasound over the carotid artery (in the neck). | 6 & 12 months | No |
Secondary | Ambulatory Systolic Blood Pressure | Average systolic blood pressure over a 24 hour time period. | 6 & 12 months | No |
Secondary | Clinic Systolic Blood Pressure | Average systolic blood pressure from in clinic final 2 (out of 3) readings | 6 & 12 months | No |
Secondary | Ambulatory Diastolic Blood Pressure | Average diastolic blood pressure over a 24 hour time period. | 6 & 12 months | No |
Secondary | Clinic Diastolic Blood Pressure | Average diastolic blood pressure from in clinic final 2 (out of 3) readings | 6 & 12 months | No |
Secondary | Composite score of memory tasks from Cambridge Brain Sciences Cognitive Battery | 6 & 12 months | No | |
Secondary | Composite score of executive function tasks from Cambridge Brain Sciences Cognitive Battery | 6 & 12 months | No | |
Secondary | Composite score of concentration tasks from Cambridge Brain Sciences Cognitive Battery | 6 & 12 months | No | |
Secondary | Total balance score | Total score calculated from the the Fullerton Advanced Balance scale | 6 & 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00747396 -
The Bucharest Early Intervention Project
|
N/A | |
Completed |
NCT01407770 -
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
|
||
Completed |
NCT02394899 -
Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease
|
N/A | |
Completed |
NCT02274883 -
The Effect of Feeding Infant Formula With Enriched Protein Fractions
|
N/A | |
Enrolling by invitation |
NCT02066571 -
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
|
Phase 2 | |
Completed |
NCT02780739 -
INSIGHT, A Comprehensive, Multidisciplinary Brain Training System
|
N/A | |
Completed |
NCT01359215 -
Childhood Anesthesia and Cognitive Function
|
N/A | |
Completed |
NCT02461693 -
Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT
|
N/A | |
Completed |
NCT01868165 -
Assessing the Impact of Calcium Channel Blockers on COGnitive Function in the Very Elderly (AI-COG)
|
||
Completed |
NCT02630667 -
The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition
|
N/A | |
Completed |
NCT01375348 -
Relationship Between Cognitive Function and Pain
|
Phase 3 | |
Completed |
NCT02853279 -
Physical Activity and Intermittent Exercise Training for Cardiovascular and Cognitive Gain in Obese Women
|
N/A | |
Completed |
NCT00894205 -
Neuropsychological Effects of Strengthening Exercise for Older Adults
|
Phase 2 | |
Completed |
NCT04442477 -
Neurodevelopment at 5.5 Years of Age in Children Who Received Infant Formula With Enriched Protein Fractions
|
||
Completed |
NCT01167400 -
Cybercycling for Cognitive Health
|
N/A | |
Completed |
NCT03137836 -
Classroom Standing Desks for Reducing Sitting Time in Children
|
N/A | |
Completed |
NCT00841321 -
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
|
Phase 2 | |
Active, not recruiting |
NCT01504633 -
Nutrigenomics, PUFA, Iron and Cognition Amongst Under-two-year-old Indonesian Children
|
N/A | |
Completed |
NCT02726906 -
Lifestyle Enriching Activities for Research in Neuroscience Intervention Trial: LEARNit Study
|
N/A | |
Not yet recruiting |
NCT02123355 -
The Effect of Dexmedetomidine to Cognition of Geriatrics in Prolonged Surgery
|
Phase 4 |